AUDIO CASSETTE ORDER FORM:

1998 International Conference on Emerging Infectious Diseases



ORDERING INFORMATION

Sunday, March 8, 1988

 

OGS $ 16.00 (2 Tapes) Openinng General Session

Moderators:
D. PETER DROTMAN, National Center for Infectious Diseases (NCID), Centers for Disease Control and Prevention (CDC), Atlanta, GA; Program Chair, International Conference on Emerging Infectious Diseases
GUS BIRKHEAD, New York State Department of Health, Albany, NY; President, Council of State and Territorial Epidemiologists

Speakers:
JAMES HUGHES, Director, NCID, CDC, Atlanta, GA

ANTHONY FAUCI, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

DAVID SATCHER, Assistant Secretary for Health and Surgeon General, Department of Health and Human Services, Washington, DC (invited)

DAVID HEYMANN, Division of Emerging and Other Communicable Diseases, World Health Organization (WHO), Geneva, Switzerland

JOSHUA LEDERBERG, Nobel Laureate, Rockefeller University, New York, NY


Monday, March 9, 1998

 

PS-01 $ 8.00 Plenary Session I: The Emerging World of Foodborne Disease: More Questions and Answers

Moderator:
PAUL BLAKE, Georgia State Health Department, Atlanta, GA

Speaker:
Foodborne Diseases: Are They Really Emerging Infections? MICHAEL OSTERHOLM, Minnesota State Health Department, Minneapolis, MN



PS-02 $ 8.00 Plenary Session II: Detection of Novel Agents

Moderator:
JOSEPH McDADE, NCID, CDC, Atlanta, GA

Speaker:
Detection of Previously-Unrecognized Microbial Pathogens. DAVID RELMAN, Departments of Medicine, Microbiology, and Immunology, Stanford University, Palo Alto, CA



PS-03 $ 8.00 Plenary Session III: Vector-Borne Infectious Diseases

Moderator:
ALAN BARBOUR, University of California, Irvine, CA

Speaker:
Resurgent Vector-Borne Diseases as a Global Public Health Problem. DUANE GUBLER, Division of Vector-Borne Infectious Diseases, NCID, CDC, Fort Collins, CO



PS-04 $ 8.00 Plenary Session IV: Infectious Causes of Chronic Diseases

Moderator:
MATTHEW McKENNA, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA

Speaker:
GAIL CASSELL, Eli Lilly Research Laboratories, Indianapolis, IN



IP-01 $ 8.00 Invited Panel 01: New Approaches to Surveillance and Control of Emerging Foodborne Diseases

The epidemiology of foodborne disease is changing as new pathogens emerge, appear in new foods, and become more difficult to treat. These new challenges require new strategies to detect the pathogens and the outbreaks they cause, new control measures that can prevent them from being transmitted early in the chain from farm to table, and new measures to reduce antimicrobial resistance in foodborne pathogens. The speakers will outline some of the remarkable recent developments in this growing arena.

Conveners:
JON COUNTS, Washington State Public Health Laboratory, Seattle, WA
ROBERT TAUXE, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA
DENNIS LANG, Division of Infectious Disease and Office of Epidemiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD

Moderators:
DALE MORSE, Wadsworth Center, New York State Department of Health, Albany, NY
STUART NIGHTINGALE, Food and Drug Administration, Rockdale, MD

Speakers:
Introduction: Emerging Foodborne Diseases and the National Food Safety Initiative. ROBERT TAUXE, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA

The Basic Research Agenda for Foodborne Diseases at the National Institutes of Health. DENNIS LANG, Division of Infectious Disease and Office of Epidemiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD

Laboratory-Based Surveillance for the 21st Century: The National Molecular Surveillance Network. BALASUBRA SWAMINATHAN, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA

From Bench to Barn: Translating Pathogenesis into New Approaches to the Prevention of Foodborne Diarrheal Illnesses. ALISON O'BRIEN, Microbiology and Immunology, Uniformed Services University for the Health Sciences, Bethesda, MD

Vancomycin-Resistant Enterococci in Animals and Food: Public Health Risks in Association with the Use of Glycopeptides in Food Animals in Europe. HENRIK WEGENER, Danish Zoonosis Centre, Danish Veterinary Laboratory, Copenhagen, Denmark



IP-02 $ 8.00 Invited Panel 02: International Cooperation

This panel brings together experts from various organizations actively involved in addressing emerging infectious diseases on a global scale. Speakers from the World Health Organization, the European Union, the U.S. Department of Defense, and others, will summarize existing collaborations and discuss opportunities for new initiatives. An open discussion will follow their presentations.

Conveners:
DAVID HEYMANN, Division of Emerging and Other Communicable Diseases, World Health Organization (WHO), Geneva, Switzerland
JAMES LeDUC, NCID, CDC, Atlanta, GA

Moderators:
DAVID HEYMANN, Division of Emerging and Other Communicable Diseases, WHO, Geneva, Switzerland
JAMES LeDUC, NCID, CDC, Atlanta, GA

Speakers:
DAVID HEYMANN, Division of Emerging and Other Communicable Diseases, WHO, Geneva, Switzerland

The Development of International Surveillance Within the European Union. CHRISTOPHER BARTLETT, Public Health Laboratory Service, London, England, UK

The Role of U.S. Development Assistance in Addressing Emerging Infectious Diseases. NILS DAULAIRE, U.S. Agency for International Development, Washington, DC

MICHAEL McCARTHY, U.S. Navy, U.S. Department of Defense, Washington, DC

Strengthening Laboratory Capacity for Disease Prevention and Epidemic Control in Africa: An Urgent and Emerging Subject for International Collaboration. OYEWALE TOMORI, WHO, Harare, Zimbabwe

JOTNA SOKHEY, National Institute of Communicable Diseases, New Delhi, India (invited)

LINDA VOGEL, U.S. Department of Health and Human Services, Washington, DC



IP-03 $ 8.00 Invited Panel 03: Immune-Deficient Populations

The panel will address opportunistic infections (OIs) in immunocompromised populations that are increasing, that is, populations in which OIs represent emerging infectious diseases. The panel will focus on persons with HIV/AIDS, bone marrow and solid organ transplant recipients, and the elderly; speakers will address challenges posed by OIs in terms of surveillance, research priorities, and prevention.

Conveners:
JONATHAN KAPLAN, Division of AIDS, STDs, and TB Laboratory Research (DASTLR), NCID, CDC, Atlanta, GA
GARY ROSELLE, VA Medical Center, Cincinnati, OH
KENT SEPKOWITZ, Memorial Sloan-Kettering Cancer Center, New York, NY
Moderators: JONATHAN KAPLAN, DASTLR, NCID, CDC, Atlanta, GA
GARY ROSELLE, VA Medical Center, Cincinnati, OH
KENT SEPKOWITZ, Memorial Sloan-Kettering Cancer Center, New York, NY

Speakers:
Opportunistic Infections Associated with HIV/AIDS in the Developing World. ALISON GRANT, Infectious Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, UK

The Evolving Phase of HIV/AIDS as a Result of the Implementation of Viral-Load Driven Antiretroviral Therapy. ROBERT HOGG, Centre of Excellence on HIV/AIDS, and Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC

Opportunistic Infections Associated with Bone Marrow and Solid Organ Transplantation. ROBERT RUBIN, Harvard University and Massachusetts Institute of Technology, Boston, MA

Opportunistic Infections Associated with Aging. CAROL KAUFFMAN, VA Medical Center and University of Michigan Medical School, Ann Arbor, MI



IP-04 $ 8.00 Invited Panel 04: Vaccine-Preventable Diseases

The panel will address four main issues of vaccine development and use in emerging infectious diseases: 1) Diseases that are major public health problems, affecting large numbers of people, for which no vaccine currently exists. This will address issues involved in basic laboratory research (e.g., dengue, respiratory syncytial virus, malaria, HIV). 2) Diseases for which there is an existing licensed vaccine, but the vaccine is not optimal and alternative vaccines are under development. Issues include assessing immunity, conjugate vaccines, vaccine safety, and delivery strategies (e.g., pertussis, N. meningitidis A and C, Japanese B encephalitis, tuberculosis). 3) Diseases for which there is an existing vaccine that is not being used effectively. Reasons range from public policy to vaccination strategies (e.g., diphtheria, yellow fever, N. meningitidis A and C). 4) Develop ment of vaccines that would have a specialized or limited use, such as controlling an outbreak or military use. Issues include special development needs, such as government funding, safety issues, and identification of a limited target group for the vaccine (e.g., Lassa fever, Ebola, hantavirus).

Conveners:
ROGER BERNIER, National Immunization Program, CDC, Atlanta, GA
ALISON MAWLE, NCID, CDC, Atlanta, GA
GEORGE CURLIN, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD
CAROLYN HARDEGREE, Food and Drug Administration (FDA), Washington, DC
ELAINE ESBER, FDA, Washington, DC
J. W. LEE, World Health Organization, Geneva, Switzerland
MYRON LEVINE, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD

Moderators:
ROBERT BREIMAN, National Vaccine Program Office, CDC, Atlanta, GA
CAROLYN HARDEGREE, FDA, Washington, DC

Speakers:
Malaria Vaccine. LEE HALL, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD

Influenza Vaccine. CLAUDE HANNOUN, Institut Pasteur, Paris, France

Meningitis Vaccine. DEO BARAKAMFITIYE, Office of Prevention and Control of Diseases, Regional Office for Africa, World Health Organization, Harare, Zimbabwe

Limited Use Vaccines. ALAN SCHMALJOHN, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD



IP-05 $ 8.00 Invited Panel 05: Host Genes and Infectious Diseases

This panel will present data on host genes that influence susceptibility to, or protection from, infectious diseases, including Hantaan virus infections, HIV infections, Lyme disease, and tuberculosis. The implications of these findings for prevention or intervention strategies, such as vaccine development or other therapies, will be discussed.

Conveners:
GUS BIRKHEAD, Council of State and Territorial Epidemiologists, New York State Department of Health, Albany, NY
OLEN KEW, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA
ALTAF LAL, Division of Parasitic Diseases, NCID, CDC, Atlanta, GA
JANET McNICHOLL, Division of AIDS, Sexually Transmitted Diseases, and TB Laboratory Research, NCID, CDC, Atlanta, GA

Moderators:
GUS BIRKHEAD, Council of State and Territorial Epidemiologists, New York State Department of Health, Albany, NY
JANET McNICHOLL, Division of AIDS, Sexually Transmitted Diseases, and TB Laboratory Research, NCID, CDC, Atlanta, GA

Speakers:
Susceptibility MHC Haplotype in Severe Puumala Hantavirus Infection. ANTTI VEHARI, Department of Virology, University of Helsinki, Helsinki, Finland

Host Susceptibility to TB in Africa. RICHARD BELLAMY, Wellcome Trust Center for Human Genetics, Oxford, UK

HLA and the Pathogenesis of Lyme Arthritis. ALLEN STEERE, Rheumatology and Immunology, New England Medical Center, Boston, MA

Host Genes, HIV Susceptibility, and Disease Course. RICHARD KASLOW, Department of Epidemiology, University of Alabama, Birmingham, AL



LS-01 $ 8.00 Special Keynote Address: Perspectives on Disease Eradication

Moderator:
DAVID SATCHER, Assistant Secretary for Health and Surgeon General, Department of Health and Human Services, Washington, DC (invited)

Special Keynote Address: THE HONORABLE DONNA SHALALA, Secretary of Health and Human Services, Washington, DC

Perspectives on Disease Eradication

Conveners:
BRIAN MAHY, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA D. PETER DROTMAN, NCID, CDC, Atlanta, GA

Moderator:
WALTER ORENSTEIN, National Immunization Program, CDC, Atlanta, GA

Speakers:
WILLIAM FOEGE, Rollins School of Public Health, Emory University, Atlanta, GA
DONALD HOPKINS, The Carter Center, Atlanta, GA



IP-06 $ 8.00 Invited Panel 06: Global Climate Change

This panel will give an overview of the current issues associated with climate change as it relates to the emergence and spread of infectious diseases. Instructional presentations will be given on what is and is not known about climate change. Cholera will be used as an example of how climate change may affect disease distribution and the type of research being conducted. The pros and cons of whether climate change is or will become a major contributing factor to the emergence or reemergence of infectious diseases will be discussed.

Conveners:
DUANE GUBLER, Division of Vector-Borne Infectious Diseases, NCID, CDC, Fort Collins, CO
MICHAEL HALL, National Oceanic and Atmospheric Administration, Washington, DC
WILLIAM SPRIGG, Board on Atmospheric Sciences and Climate, National Academy of Sciences, National Research Council, Washington, DC
ERNEST TAKAFUJI, Walter Reed Army Institute of Research, Washington, DC

Moderators:
DUANE GUBLER, Division of Vector-Borne Infectious Diseases, NCID, CDC, Fort Collins, CO
MICHAEL HALL, National Oceanic and Atmospheric Administration, Washington, DC
WILLIAM SPRIGG, Board on Atmospheric Sciences and Climate, National Academy of Sciences, National Research Council, Washington, DC
ERNEST TAKAFUJI, Walter Reed Army Institute of Research, Washington, DC

Speakers:
DUANE GUBLER, Division of Vector-Borne Infectious Diseases, NCID, CDC, Fort Collins, CO
PAUL EPSTEIN, Harvard Medical School, Cambridge, MA
PAUL REITER, Division of Vector-Borne Infectious Diseases, NCID, CDC, San Juan, PR
JAGADISH SHUKLA, Center for Ocean-Land-Atmosphere Studies, Institute of Global Environment and Society, Inc., Calverton, MD
RITA COLWELL, University of Maryland Biotechnology Institute, College Park, MD
JULI TRTANJ, National Oceanic and Atmospheric Administration, Washington, DC
WILLIAM SPRIGG, Board on Atmospheric Sciences and Climate, National Academy of Sciences, National Research Council, Washington, DC
ERNEST TAKAFUJI, Walter Reed Army Institute of Research, Washington, DC



SP-01 $ 8.00 Special Session 1: Sentinel Networks

The use of sentinel events to enhance surveillance is an effective public health tool that has proven useful in the monitoring of many diseases. Sentinel networks, linking groups of participating individuals or organizations to a central data receiving and processing center, have been particularly helpful in monitoring specific infections or designated classes of infections. Three provider-based sentinel networks were established to improve our ability to detect and monitor emerging infections; these are the Infectious Disease Society of America, which has established a sentinel network of infectious disease physicians, 11 academically affiliated emergency departments, and the International Society of Travel Medicine, which has developed a network of travel medicine clinics.

Convenor:
ROBERT PINNER, NCID, CDC, Atlanta, GA

Moderators:
DAVID TALAN, Department of Emergency Medicine, Olive View-UCLA Medical Center, Sylmar, CA
JEFFREY DAVIS, Wisconsin Department of Health and Social Services, Madison, Wisconsin

Speakers:
EMERGEncy ID Net: Emergency Department-Based Sentinel Surveillance for Emerging Infectious Diseases. DAVID TALAN, Department of Emergency Medicine, Olive View-UCLA Medical Center, Sylmar, CA

The IDSA Emerging Infections Network. LARRY STRAUSBAUGH, Department of Infectious Diseases, Portland VA Medical Center, Portland, OR

GeoSentinel: Global Surveillance Through Emerging Infections Travel Clinics. PHYLLIS KOZARSKY, International Society of Travel Medicine, Atlanta, GA.



SS-01 $ 8.00 Slide Session 1: Molecular Epidemiology

Moderators:
OLEN KEW, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA
RUTH BERKELMAN, CDC, Atlanta, GA

Presentations:
Genetic Variation of Human Herpesvirus 8 (HHV-8) Within Individuals and Among Viruses from Geographically Diverse Sources. Y.X. MENG1, T.J. SPIRA 1, G.J. BHAT2, C. BIRCH3, J. DRUCE3, B.R. EDLIN4, R. EDWARDS3, C. GUNTHEL5, R. NEWTON6, F.R. STAMEY1, D. WHITBY6, C. WOOD7, P.E. PELLETT1, THE ATLANTA HHV-8 WORKING GROUP. 1 CDC, Atlanta, GA; 2 Zambia Univ. Teaching Hosp., Lusaka Zambia; 3Vectorial Infect. Dis. Ref. Lab., Fairfield, Australia; 4 Univ. of CA, San Francisco, CA; 5 Emory Univ., Atlanta, GA; 6 Inst. Cancer Res., London, UK; 7 Univ. of NE, Lincoln, NE

Phylogenetic Analysis of the Hepatitis E Virus Genomes. S.A. TSAREV,* L.N. BINN, P.J. GOMATOS , R.R. ARTHUR, M.K. MONIER, C.F. LONGER, B.L. INNIS. Walter Reed Army Inst. of Res., Washington, DC; Naval Med. Res. Unit No. 3, Cairo, Egypt; Abbassia Fever Hospital, Cairo, Egypt

Current Issues in Molecular Epidemiologic Studies of Plasmodium falciparum. A. A. ESCALANTE,* A. A. LAL. CDC, Atlanta, GA

Extensive Allelic Variation in the sic Gene Among Serotype M1 Group A Streptococcus Strains Recovered in Ontario, Canada. N. HOE, A. MCGEER, D. E. LOW, B. WILLEY, J. M. MUSSER. Baylor Coll. of Med., Houston, TX; Mt. Sinai Hosp., Toronto, Canada

The DNA Polymerase Inhibitor Cidofovir (Hpmpc) is a Potential Antiviral Therapeutic Agent for the Treatment of Monkeypox. J. W. HUGGINS*, D. SMEE, M. BRAY. U.S. Army Medical Res. Inst. of Infect. Dis., Ft. Detrick, MD

Molecular Insights into the Epidemiology of Astrovirus Gastroenteritis. S.S. MONROE, * G.D. BELLIOT, J.S. NOEL, M.P.G. KOOPMANS. CDC, Atlanta, GA; Natl. Inst. for Publ. Health and the Environment, Bilthoven, The Netherlands



SS-02 $ 8.00 Slide Session 02: Food Safety

Moderators:
DAVID CARPENTER, Illinois Public Health Laboratories, Springfield, IL
GEORGE HARDY, International Life Sciences Institute North America, Washington, DC

Presentations:
Detection of an Outbreak of Escherichia coli O157:H7 Enterocolitis Associated with Consumption of Commercial Hamburger Patties. P.J. SHILLAM, R.E. HOFFMAN, D.M. HELTZEL, C.P. LATTUADA2, J.L. BEEBE, CO Dept. of Publ. Health and the Environment, Denver, CO; 2U.S. Dept. of Agri., Athens, GA

Enterohemorrhagic Escherichia coli O157:H7 Present in Radish Sprouts. Y. ITOH, Y. SUGITA-KONISHI, Y. KUDO, M. IWAKI,* F. KASUGA, N. SAITO, Y. NOGUCHI, S. KUMAGAI. Natl. Inst. of Infect. Dis., Tokyo, Japan

An Outbreak of Escherichia coli O157:H7 Infections and Hemolytic-Uremic Syndrome Associated with a Single Brand of Unpasteurized Apple Cider. E.HILBORN, P. MSHAR, T. FIORENTINO, Z. DEMBEK, T. BARRETT, M. CARTTER. CDC, Atlanta, GA; CT Dept. of Publ. Health, Hartford, CT, currently with U.S. EPA, Res. Triangle Park, NC; CT Dept. of Publ. Health, Hartford, CT; Yale Univ. Sch. of Publ. Health, New Haven, CT; CT Dept. of Publ. Health, Hartford, CT

An Outbreak of Hepatitis A Associated with Frozen Strawberries, Michigan, 1997. Y. HUTIN, V. POOL, S. GOLDSTEIN, C. WHITTIER, J. CARVER, J. WETH, P. MAKOWSKI, W. HALL, J. ALTAMIRANO, J. TILDEN, S. GOTTLIEB, I. WILLIAM, B. BELL, C. SHAPIRO, M. ALTER. CDC, Atlanta, GA; MI Dept. of Health and MI Dept. of Agri., Lansing, MI; Calhoun County Dept. of Health, Battle Creek, MI; Saginaw County Dept. of Health, Saginaw, MI

Epidemiology of Cyclospora cayetanensis Infection Among Outpatients in Guatemala. C. BERN*, D.B. HERNANDEZ, M.J. ARROWOOD, M.B. LOPEZ, A.M. De MERIDA, B.L. HERWALDT, R. KLEIN. CDC, Guatemala City, Guatemala, and Atlanta, GA

Molecular Epidemiology of Enterohemorrhagic Escherichia coli (EHEC) O157 Outbreak and Sporadic Cases in Japan During 1996-1997. S. IYODA,* J. TERAJIMA, A. WADA, Y. INAGAKI, H. IZUMIYA, K. ITOH, K. TAMURA, H. WATANABE. Natl. Inst. of Infect. Dis., Tokyo, Japan



SS-03 $ 8.00 Slide Session 03: Vector-Borne Diseases

Moderators:
MATTHEW CARTTER, Connecticut Department of Public Health, Hartford, CT
SCOTT HALSTEAD, Office of Naval Research, U.S. Navy, Arlington, VA

Presentations:
A Model Surveillance System for Mosquito-Borne Arboviruses. W. K. REISEN,* B. F. ELDRIDGE, T. W. SCOTT. Univ. of CA, Davis, CA

Outbreak of Ross River Virus Infection in Sydney, Australia. D.E. DWYER,* J. AMIN, A. CAPON, L. HUESTON. CIDMLS, ICPMR, Westmead Hosp., Westmead, and Western Sector Publ. Health Unit, Parramatta, NSW, Australia

Expression of Outer Surface Proteins A and C of Borrelia burgdorferi in Ixodes ricinus Ticks Removed from Humans. V. FINGERLE *, G. LIEGL, B. WILSKE. Max v. Pettenkofer Inst., Ludwig Maximilians Univ., Munich, Bavaria, Germany

Replication and Antigenicity of the Human Granulocytic Ehrlichiosis (HGE) Agent Grown in Ixodes Tick Cell Culture. U.G. MUNDERLOH1,* S.D. JAURON1, S.F. HAYES1, J.M. HAUTMAN2, G.G. AHLSTRAND2, L.A. COLEMAN2, R.C. JOHNSON2, J.L. GOODMAN2. 1 Univ. of MN, St. Paul and Minneapolis, MN; 2Rocky Mtn. Laboratories, NIH, Hamilton, MT

Utility of Active and Passive Surveillance for Emerging Tick-borne Diseases. J. MEEK,* P. GUARINO, B. KUSHA, J. IJDO, S. TENUTA, C. BRINKMAN, E. FIKRIG, M. CARTTER, R. RYDER. CT Emerging Infections Program, New Haven, CT; Dept. Publ. Health, Hartford, CT

Microevolution of Chagas' Disease Vectors and the Relevance to Molecular Genetic and Traditional Control Approaches. C.B. BEARD,* R.V. DURVASULA, C. CORDON-ROSALES. CDC, Atlanta, GA; Yale Univ. Sch. of Med., New Haven, CT; CDC/MERTUG, Guatemala City, Guatemala



SP-02 $ 8.00 Special Session 02: FoodNet/Enter-net: Emerging Surveillance Programs for Foodborne Diseases

The public health challenge of foodborne diseases are changing rapidly; in recent years, new and emerging foodborne pathogens have been described and changes in food production have led to new food safety concerns. A central feature of the national and international strategies for responding to these challenges has been the establishment of multi-state and international collaborative efforts, including FoodNet and Enter-net such networks serve as models for responding to the continuing threat of emerging infectious diseases.

Convener:
FREDERICK ANGULO, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA

Moderators:
MONICA FARLEY, Emory School of Medicine and Atlanta VA Medical Center, Atlanta, GA
FREDERICK ANGULO, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA

Presentations:
Population-Based Estimates of the Burden of Diarrheal Illness: FoodNet 1996-1997. DUC VUGIA, California Department of Health Services, Berkeley, CA

The FoodNet Physicians Survey: Implications for Foodborne Disease Surveillance. THOMAS HENNESSEY, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA

Case-Control Study of Sporadic Escherichia coli O157:H7 Infections in 5 FoodNet Sites. HEIDI KASSENBORG, Minnesota Department of Health, Minneapolis, MN

Enter-net Surveillance Curtails International Outbreaks of Foodborne Pathogens. IAN FISHER, Communicable Disease Surveillance Center, London, UK



SS-04 $ 8.00 Slide Session 04: Detection of Novel Agents

Moderators:
LUCY TOMPKINS, Stanford University Medical School, Palo Alto, CA
MICHAEL SKEELS, Oregon State Public Health Laboratory, Portland, OR

Presentations:
Phenotypic and Molecular Characterization of a New Vibrio Causing Oubreaks of Wound Infection and Bacteremia in Israel. D.N. CAMERON,* D. WYKSTRA, N. BISHARAT, V. AGMON, THE ISRAEL VIBRIO WORKING GROUP. CDC, Atlanta, Ga; Ha'Emek Medical Ctr., Afula, Israel; Govt. Central Labs., Jerusalem, Israel

Novel Hepatitis E Virus (HEV) Isolates from Patients with Acute Hepatitis in the United States and Europe: Evidence for at Least Four Major Genotypes of HEV. G. G. SCHLAUDER1,* G. J. DAWSON1, J. C. ERKER1, S. M. DESAI1, P. Y. KWO 2, D. L. SMALLEY 3, M. F. KNIGGE, J. E. ROSENBLATT 4, A. ZANETTI 5, I. K. MUSHAHWAR1. 1 Abbott Labs., N. Chicago, IL; 2 IN Univ. Medical Ctr., Indianapolis, IN; 3Univ. of TN, Memphis, TN; 4 Mayo Clinic, Rochester, MN; 5Univ. of Milan, Milan, Italy

Rotavirus Strain Surveillance Reveals a Possible Fifth Important G Type in the United States. J.R. GENTSCH, M. RAMACHANDRAN, U. PARASHAR, S. JIN, C. KIRKWOOD, P. WOODS, J. HOLMES, J. BRESEE, R.I. GLASS, THE NATL. ROTAVIRUS STRAIN SURVEILLANCE SYSTEM. CDC, Atlanta, GA

Polyphasic Identification and Characterization of Emerging Bacterial Pathogens. R.S. WEYANT,* M.I. DANESHVAR, J.G. JORDAN, J.P. MacGREGOR, D.G. HOLLIS, L.W. MAYER, A.M. WHITNEY, A.G. STEIGERWALT, D.J. BRENNER. CDC, Atlanta, GA



SS-05 $ 8.00 Slide Session 05: Viral Vaccines

Moderators:
JOHN LA MONTAGNE, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
NEAL HALSEY, Department of International Health, Johns Hopkins University, Baltimore, MD

Presentations:
Evaluation of Gene Expression and Gold Bead Distribution in Guinea Pigs Vaccinated with an Ebola Glycoprotein Naked DNA/Gene Gun Vaccine. L. VANDERZANDEN,* D. CUSTER , C. SCHMALJOHN, K. STEELE. U.S. Army Med. Res. Inst. of Infect. Dis., Ft. Detrick, MD

Current Status of the Studies with a Live Attenuated Junin Virus Vaccine (Candid 1) Against Argentine Hemorrhagic Fever. D. ENRIA*, M. FEUILLADE, S. LEVIS, A. BRIGGILER, A. AMBROSIO, M. SAAVEDRA, L. RIERA, J. BECKER, G. CALDERON, N. PINI, J. GARCIA, J. SOTTOSANTI, G. AVILES, M. SABATTINI. Instituto Nacional de Enfermedades Virales Humanas, Pergamino, Argentina

Pediatric Rotavirus-associated Hospitalizations in New York State, 1993-1996. H. G. CHANG,* H.G.CICIRELLO, D. L. MORSE, P. F. SMITH. New York State Department of Health, Albany, NY (HGC,DLM,PFS); N. Amer. Vaccine, Inc., Beltsville, MD

Expanded Phase I Trial of Four Monovalent Dengue Virus Vaccine Candidates. R. EDELMAN,* C.O. TACKET, S.S. WASSERMAN, N. KANESA-THASAN, R. PUTNAK, A. KING, W. SUN, D. TANG, S.A. VAN ALBERT, C.H. HOKE, K.H. ECKELS, D.W. VAUGHN, T. KLEIN, M. TURRELL, M. SARDELIS, B.L. INNIS. Univ. of MD Sch. of Med., Baltimore, MD; Walter Reed Army Inst. of Res., Washington, DC; Armed Forces Res. Inst. of Medical Sciences, Bangkok, Thailand; U.S. Army Medical Res. Inst. of Infect. Dis., Frederick, MD



SS-06 $ 8.00 Slide Session 06: International Cooperation

Moderators:
STEPHEN BLOUNT, Office of Global Health, CDC, Atlanta, GA
ROBERT BLACK, Department of International Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD

Presentations:
Microbialpolitik: Infectious Diseases and International Relations. D. P. FIDLER.* Indiana Univ. Sch. of Law, Bloomington, IN

The APEC Emerging Infections Network: Prospects for Comprehensive Information Sharing on Emerging Infections within the Asia Pacific Economic Cooperation. A.M. KIMBALL*; P. O CARROLL, C. HORWITCH, S. ARJOSO, C. KUNANUSONT, Y.S. LIN, C. MEYER, L. SCHUBERT, P. DUNHAM. Univ. of WA, Seattle, WA; Min. of Publ. Health, Thailand (Kunanusont); Min. of Health, Indonesia

European Surveillance of Travel Associated Legionnaires Disease. C.R. LANE*, C.A JOSEPH, C.L.R. BARTLETT on behalf of the European Working Group for Legionella Infections. PHLS Communicable Dis. Surveillance Ctr., London, UK

Arizona-Sonora Binational STD Study. B. DJAMBAZOV,* L. ORTEGA 1, J.L. NAVARRO 2, J. ZAPIEN, A. GIULIANO 3, C. DENMAN 4. 1 AZ Dept. of Health Svcs., Phoenix, AZ; 2 Secretaria de Salud Publica de Sonora, Hermosillo, Sonora, Mexico; 3 Univ. of Arizona, Tucson, AZ; 4 El Colegio de Sonora, Hermosillo, Sonora, Mexico



SS-07 $ 8.00 Slide Session 07: Bacterial and Mycotic Diseases

Moderators:
DAVID RIMLAND, Department of Medicine, Emory University School of Medicine and VA Medical Center, Atlanta, GA
BRUCE LEVIN, Department of Biology, Emory University, Atlanta, GA

Presentations:
The Costs and Benefits of Vaccinating Against Lyme Disease: A Decision Analysis. M.I. MELTZER*1, D.T. DENNIS2, K.A. ORLOSKI2. 1CDC, Atlanta, GA; 2CDC, Ft. Collins, CO

Possible Relationship of Pneumococcal Surface Adhesin A Antibody Level to Nasopharyngeal Carriage of Streptococcus pneumoniae in Young African Infants. S. K. OBARO,* 1, K.J.W.P. McADAM, 1 J.A. THARPE, 2, E. ADES, 2, G.M. CARLONE, 2, J.S. SAMPSON2. 1MRC Labs., The Gambia, Africa; 2CDC, Atlanta, GA

Trends in Mortality due to Invasive Mycotic Diseases in the United States, 1980-1994. M.M. McNEIL,* S.L. NASH, R.A. HAJJEH, L.A. CONN, B.D. PLIKAYTIS. CDC, Atlanta, GA

Mapping and Immunogenicity of Phage Display Library Selected Peptides of the Pneumococcal PsaA Common Protein. J.L. ZEILER*, J.S. SAMPSON, G.M. CARLONE, E.W. ADES, J.A. THARPE, M.A.J. WESTERINK*. *Medical Coll. of OH, Toledo, OH; CDC, Atlanta, GA



USAID $ 8.00 USAID Session: Formal Release of USAID's Strategy on Infectious Diseases and Initial $50 Million Investment

Moderator:
NILS DAULAIRE, U.S. Agency for International Development, Washington, DC

Speakers:
JOY RIGGS-PERLA, U.S. Agency for International Development, Washington, DC
IRENE KOEK, U.S. Agency for International Development, Washington, DC
PAUL DELAY, U.S. Agency for International Development, Washington, DC
VICTOR BARBIERO, U.S. Agency for International Development, Washington, DC
DENNIS CARROLL, U.S. Agency for International Development, Washington, DC
ANTHONY BONI, U.S. Agency for International Development, Washington, DC
TIM RIESER, Foreign Affairs Subcommittee of the Appropriations Committee, U.S. Senate, Washington, DC



Tuesday, March 10, 1998

 

PS-05 $ 8.00 Plenary Session V: Bioterrorism

Moderator:
GARY CHRISTOPHERSON, U.S. Department of Defense, Arlington, VA

Speaker:
D. A. HENDERSON, Johns Hopkins University School of Public Health, Baltimore, MD



PS-06 $ 8.00 Plenary Session VI: Influenza

Moderator:
WALTER DOWDLE, Task Force for Child Survival and Development, Atlanta, GA

Speaker:
Influenza Viruses. ROBERT WEBSTER, St. Jude Medical Center, Memphis, TN



PS-08 $ 8.00 Plenary Session VIII: Emerging Zoonoses

Moderator:
JAMES CURRAN, Rollins School of Public Health, Emory University, Atlanta, GA

Speaker:
Emerging Zoonotic Diseases. FREDERICK MURPHY, School of Veterinary Medicine, University of California, Davis, CA



IP-07 $ 8.00 Invited Panel 07: Emerging Zoonoses

The panel on emerging zoonoses will emphasize the special significance of agents maintained in animal reservoirs and those that are transmitted by arthropod vectors as potential causes of epidemics and newly recognized diseases of humans. Speakers will use examples of specific zoonotic diseases to illustrate the methods used to understand their epidemiology and to point out areas in which research and resources are needed. In addition to describing the significance of zoonotic agents as causes of human disease, special emphasis will be placed on the challenge of surveillance for potential pathogens within nonhuman species prior to their emergence in humans.

Conveners:
JAMES CHILDS, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA
GARY CLARK, Division of Vector-Borne Infectious Diseases, NCID, CDC, San Juan, PR
EMILIO DeBESS, Oregon Department of Human Resources, Portland, OR
DAVID DENNIS, Division of Vector-Borne Infectious Diseases, NCID, CDC, Fort Collins, CO

Moderators:
SUZANNE JENKINS, Office of Epidemiology, Virginia State Department of Health, Richmond, VA
JAMES CHILDS, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA
DAVID DENNIS, Division of Vector-Borne Infectious Diseases, NCID, CDC, Fort Collins, CO

Speakers:
Zoonoses and Arbovirus Pathogens as Emerging Infectious Diseases. ROBERT SHOPE, University of Texas Medical Branch, Galveston, TX

Factors Associated with Food-borne Zoonoses. FRANCOIS MESLIN, Division of Emerging and Other Communicable Diseases Surveillance and Control, World Health Organization, Geneva, Switzerland

Rodent-borne Zoonoses. C.J. PETERS, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA

Emerging Zoonotic Virus Surveillance: Is Preemergent Detection Possible? KARL JOHNSON, Department of Biology, University of New Mexico, Socorro, NM



IP-08 $ 8.00 Invited Panel 08: Bioterrorism as a Public Health Threat

The potential use of infectious agents as weapons of terrorism presents a serious threat to public health. Officials at the federal, state, and local level need to be prepared to respond to this threat. Panelists will discuss issues related to bioterrorism and infrastructure needs and planning necessary to ensure preparedness

Conveners:
DAVID FRANZ, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD
JAMES LeDUC, NCID, CDC, Atlanta, GA
JOSEPH McDADE, NCID, CDC, Atlanta, GA

Moderators:
DAVID FRANZ, USAMRIID, Fort Detrick, MD
JOSEPH McDADE, NCID, CDC, Atlanta, GA

Speakers:
Public Health Preparedness and Response Roles for CDC Related to Bioterrorism. SCOTT LILLIBRIDGE, Office of Emergency, Refugee, and International Health, National Center for Environmental Health, CDC, Atlanta, GA

First-hand Experience and Perspective of a State Health Department. MICHAEL SKEELS, Oregon State Public Health Laboratory, Portland, OR

Bioterrorism Preparedness: The Local Public Health Perspective. MARCELLE LAYTON, New York City Department of Public Health, New York, NY

Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents. DAVID FRANZ, USAMRIID, Fort Detrick, MD

Forensic Sciences and the Solution of the Biocrime. RANDALL MURCH, Laboratory Division, Federal Bureau of Investigation, Washington, DC



IP-09 $ 8.00 Invited Panel 09: HIV, STD, and TB Diagnostic Issues

The purpose of the session is to provide an update on advances in the laboratory diagnosis of tuberculosis, sexually transmitted diseases, and HIV infection. Specific topics will include the use of nucleic acid amplification and rapid diagnostic tests.

Conveners:
KENNETH CASTRO, Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, CDC, Atlanta, GA
HAROLD JAFFE, Division of AIDS, Sexually Transmitted Diseases, and TB Laboratory Research, NCID, CDC, Atlanta, GA
BURTON WILCKE, Vermont Department of Health Laboratory, Burlington, VT

Moderators:
STEPHEN A. MORSE, Division of AIDS, Sexually Transmitted Diseases, and TB Laboratory Research, NCID, CDC, Atlanta, GA
P. FREDRICK SPARLING, Department of Medicine, University of North Carolina, Chapel Hill, NC

Speakers:
Tuberculosis. GAIL WOOD, Clinical Microbiology, University of Texas Medical Branch, Galveston, TX

Sexually Transmitted Diseases. JULIUS SCHACHTER, Departments of Laboratory Medicine and Epidemiology and Biostatistics, University of California, San Francisco, CA

Human Immunodeficiency Virus. J. STEPHEN McD OUGAL, Division of AIDS, Sexually Transmitted Diseases, and TB Laboratory Research, NCID, CDC, Atlanta, GA



IP-10 $ 8.00 Invited Panel 10: Public Health Surveillance and Information Technology

This symposium will address the opportunities and challenges to public health in its efforts to apply modern information technology to surveillance. Speakers will present the perspectives of standards developers and state and federal health agencies.

Conveners:
BRADFORD KAY, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA
MEADE MORGAN, Epidemiology Program Office, CDC, Atlanta, GA
ROBERT PINNER, NCID, CDC, Atlanta, GA
RALPH TIMPERI, Massachusetts State Laboratory, Jamaica Plain, MA

Moderators:
ROBERT PINNER, NCID, CDC, Atlanta, GA
DENISE KOO, Division of Public Health Surveillance and Informatics, Epidemiology Program Office, CDC, Atlanta, GA

Speakers:
Applying Modern Information Technology to Reporting for Public Health the Role of Standards. CLEMENT McDONALD, Regenstrief Institute for Health Care and Indiana University School of Medicine, Indianapolis, IN
The Health Insurance Portability and Accountability Act: Opportunities and Pitfalls for Surveillance. WILLIAM BRAITHWAITE, Department of Health and Human Services, Washington, DC

The Future of Infectious Diseases Surveillance in the United States. MICHAEL OSTERHOLM, Minnesota Department of Health, Minneapolis, MN



IP-11 $ 8.00 Invited Panel 11: Travelers' Health

Over the last 150 years the world's population has grown from less than 1 billion persons in 1850 to over 6 billion persons projected by the year 2000. In the same period, the time required to circumnavigate the globe has been reduced from 365 days to 72 hours. International travel has reached unprecedented proportions; commercial airlines now carry 1.4 million persons across international borders each day. The speed and volume of international travel is one of the principal factors contributing to the global emergence of infectious diseases. This panel will explore the impact of travel on emerging infectious diseases from both the developed and developing country perspective; discuss the role of vaccination in preventing travel-related infectious diseases; and explore the implications of expanding our travel horizons beyond our own planet into habitations in space.

Conveners:
MARTIN CETRON, Division of Quarantine, NCID, CDC, Atlanta, GA
PHYLLIS KOZARSKY, International Society of Travel Medicine, Stone Mountain, GA

Moderators:
MARY WILSON, Mount Auburn Hospital, Cambridge, and Harvard University, Boston, MA
MARTIN WOLFE, Travelers' Medical Service of Washington, Washington, DC

Speakers:
JAY KEYSTONE, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada

ROBERT STEFFEN, University of Zurich and World Health Organization Collaborating Centre for Travelers' Health, Zurich, Switzerland

DAVID SHLIM, The Canadian International Water and Energy Consultants Clinic Travel Medicine Center, Kathmandu, Nepal

MICHAEL BARRATT, Johnson Space Center, National Aeronautics and Space Administration, Houston, TX



LS-02 $ 8.00 Emerging Infectious Diseases and the Media

Convener:
ROBERT HOWARD, NCID, CDC, Atlanta, GA
THOMAS SKINNER, Office of Communication, CDC, Atlanta, GA

Moderators:
THOMAS SKINNER, Office of Communication, CDC, Atlanta, GA
MARGARET WINKER, Journal of the American Medical Association, Chicago, IL

Speakers:
SHANNON BROWNLEE, U.S. News and World Report

ANITA MANNING, USA Today

LAUREN NEERGUARD, Associated Press

DAN RUTZ, CNN



IP-12 $ 8.00 Invited Panel 12: Getting the Handle Off the Proverbial Pump: Communication Works

This session will present scientific background and case studies showing health communication programs that were successful and effective in preventing and controlling infectious diseases. Epidemiologists have found that using communication methods planned and implemented with behavioral and social scientists as part of the prevention team is critical to the overall effectiveness of prevention and control programs.

Conveners:
LELA FOLKERS, Office of Health Communication, NCID, CDC, Atlanta, GA
MEREDITH HICKSON, Office of Health Communication, NCID, CDC, Atlanta, GA
STEPHEN KNOBLOCK, Illinois Department of Public Health, Springfield, IL
KATHLEEN PARKER, Division of STD Prevention, National Center for HIV, STD, and TB Prevention, CDC, Atlanta, GA

Moderators:
LELA FOLKERS, Office of Health Communication, NCID, CDC, Atlanta, GA
ENRIQUETA BOND, Burroughs Wellcome Fund, Durham, NC

Speakers:
Health Communication: An Integral Part of Infectious Disease Prevention Strategies. MARIA TERESA CERQUEIRA, Pan American Health Organization, World Health Organization

Water Vessels Projects and the Reduction of Waterborne Diarrheal Diseases. ROBERT QUICK, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA

Training of Village Health Workers in the Prevention and Control of Lassa Fever. JAMES KANU, Institut de Recherche et Biologie Appliquee de Guinee, Conakry, Guinea, West Africa

Making Infectious Disease Prevention a Part of the Healthy Islands Country Plan. GAUDEN GALEA, Institute of Health Care, University of Malta, Zebbug, Malta



SP-03 $ 8.00 Special Session 3: Enhancing State Epidemiology and Laboratory Capacity for Infectious Diseases

Convener:
DEBBIE DEPPE, NCID, CDC, Atlanta, GA

Moderators:
RICHARD HOFFMAN, Colorado Department of Public Health and Environment, Denver, CO
JON COUNTS, Washington Public Health Laboratories, Seattle, WA

A strong and flexible public health infrastructure is the best defense against any disease outbreak. Six of the 30 state and local health departments funded under the "Epidemiology and Laboratory Capacity" program will highlight activities undertaken to rebuild our nation's public health infrastructure for recognizing, responding to, and monitoring emerging infectious diseases.

Speakers:
Increasing Public Health Capacity Kansas-Style. GAIL HANSEN, Kansas Department of Health and Environment, Topeka, KS

Utility of PFGE for Outbreak Investigations in a Large Urban Health Department. DAVID DASSEY, Los Angeles County Department of Health Services, Los Angeles, CA

Electronic Communicable Disease-Reporting System in New York State. HWA-GAN CHANG, New York State Department of Health, Albany, NY

Development of Evaluation of Electronic Laboratory-Based Reporting for Infectious Disease Surveillance. JAC DAVIES, Washington State Department of Health, Seattle, WA

Models for Surveillance: Vermont's 1997 Law. JAN CARNEY, Vermont Department of Health, Burlington, VT

Expanded Hepatitis C Surveillance in a Rural State. GEOFFREY BECKETT, Maine Bureau of Health, Augusta, ME



SS-08 $ 8.00 Slide Session 08: Emerging Infectious Diseases Prevention Challenges: New and Old

Moderators:
MELINDA WHARTON, Division of Epidemiology and Surveillance, National Immunization Program, CDC, Atlanta, GA
PHYLLIS FREEMAN, Law Center, University of Massachusetts, Boston, MA

Presentations:
Seroprevalence of Hepatitis B Virus Infection Among Pregnant Women Delivering at Harare Maternity Hospital, Harare Zimbabwe. M. ADEM*, S. MADZIME, K. MAHOMED, G. B. WOELK, S. MUDZAMIRI, W.H. GEORGE, M.A. WILLIAMS. MIRT Program, Univ. of WA, Seattle, WA; Univ. of Zimbabwe Med. Sch., Harare, Zimbabwe

Occult Exposure to Bats in Oregon: Implications for Rabies Post-Exposure Prophylaxis. P.R. CIESLAK,* E.E. DEBESS, W.E. KEENE, D.W. FLEMING. Oregon Health Div., Portland, OR

Neonatal Group B Streptococcal (GBS) Disease in CT and the Impact of Hospital Prevention Policy on Early-Onset Disease. C.A. MORIN,* Q.N. PHAN, N.L. BARRETT, P.A. MSHAR, J.L. HADLER. CT Emerg. Infect. Prog., Active Bacterial Core Surveillance, Hartford, CT

Monitoring the Emergence of New Foci of Onchocerciasis (River Blindness) in the Americas. J. P. EHRENBERG 1*, G. E. COELHO 2, R. GUDERIAN 3, F. RICHARDS4. 1O.E.P.A., Guatemala City, Guatemala; 2Min. of Health, Brazilia, Brazil; 3Univ. of WA, Seattle, WA; 4CDC, Atlanta, GA

Race Differences in Pneumococcal Infection: Implications for Vaccine Prevention. L.H. HARRISON, D.M. DWYER, L. BILLMANN, A. SCHUCHAT, THE MARYLAND EMERGING INFECTIONS PROGRAM. Johns Hopkins Univ., Baltimore, MD; MD Dept. of Health and Mental Hyg., Baltimore, MD; CDC, Atlanta, GA

Studies of the Emergence of Human Monkeypox in the D. R. of Congo. J. STEWART, J. ESPOSITO, R. PEBODY, A. APLOGAN, C. ROTH, K. TSHIOKO, M. SZCZENIOWSKI. CDC, Atlanta, GA; EPIET, Brussels; Epicentre, Paris; PHLS, London; WHO, Geneva, Switzerland



SS-09 $ 8.00 Slide Session 09: Emerging Infectious Diseases Prevention Surveillance/Bioterrorism

Moderators:
JOEL GAYDOS, Henry M. Jackson Foundation, Rockville, MD, and Walter Reed Army Institute of Research, Washington, DC
DAVID STEPHENS, Department of Medicine, Emory University, Atlanta, GA

Presentations:
The Impact of Electronic Laboratory Reporting on AIDS Surveillance in New York State Exclusive of New York City (upstate NY). P. SMITH, * J. MIKL, R. MASSARONI, M. DAVISSON, D. GLEBATIS. NY Dept. of Health , Albany, NY

GIDEON: A Computer System for Global Informatics and Disease Simulation. S. A. BERGER.* Tel Aviv Medical Ctr., Tel Aviv, Israel

Real-Time, Threat-Based Antiinfective Compound Optimization as Cost-Effective Biological Warfare Countermeasures. D.A. NOEVER,* J. SHAFFER, A.M. BRITTAIN. CyberChemics, Inc., Huntsville, AL

Invasive Group A Streptococcal Infections: San Francisco Bay Area 1989-1997. D.S. SMITH1*, D. VUGIA2, B. SCHWARTZ3, P. DAILY4, A. REINGOLD5. 1 Stanford Univ. Hosp., Stanford, CA; 2 CA State Health Dept., Berkeley, CA; 3 CDC, Atlanta, GA; 4Emerg. Infect. Prog. Office, Oakland, CA; 5 Univ. of CA, Berkeley, CA

Mobile Analytical Laboratory for the Rapid Identification of Bioterrorism Agents. G.W. LONG, W.M. NELSON, B.L. MANGOLD, A. CHURILLA. Naval Medical Res. Inst., Biological Defense Res. Prog., Bethesda, MD

Population-Based Microbiologic Surveillance Used to Determine the Prevalence, Clinical Predictors, and Identity of Emerging Pathogens Responsible for Mycobacterium spp. Bloodstream Infections in Southeast Asia. L.C. MCDONALD,* L.K. ARCHIBALD, S. RHEANPUMIKANKIT, S. TANSUPHASWADIKUL, B. EAMPOKOLAP, L.B. RELLER, W.R. JARVIS. CDC, Atlanta, GA; Bamrasnaradura Infect. Dis. Hosp., Bangkok, Thailand; Duke Univ. Medical Ctr., Durham, NC



SS-10 $ 8.00 Slide Session 10: HIV/STD

Moderators:
ALAN RONALD, University of Manitoba, Winnepeg, Manitoba, Canada
HUNTER HANDSFIELD, Division of STD Prevention, National Center for HIV, STD, and TB Prevention, CDC, Atlanta, GA

Presentations:
Behavioral Interventions and Their Positive Effects on STD and HIV Prevention. D.E. MORISKY*, C.D. SNEED, T.V. TIGLAO, R. DETELS, K.Y. LIU. UCLA Sch. of Publ. Health, Los Angeles, CA

Emergence, Diversification, and Global Spread of Subtypes and Inter-subtype Recombinant HIV-1. F.E. McCUTCHAN1,* M.O. SALMINEN.1, 2., J.K. CARR 1, S. BRODINE 3, J.R. MASCOLA4, M.L. ROBB4, J.G. McNEIL, J.G.4, D.L. BIRX 4.. 1 Henry M. Jackson Foundation, Rockville, MD;2 Natl. Publ. Health Inst., Helsinki, Finland;3 Naval Health Res. Ctr., San Diego, CA; 4 Div. of Retrovirology, Walter Reed Army Inst.of Res., Rockville, MD

Evaluation of a Novel Approach to the Diagnosis of Genital Infections in Active Duty Women. A.M. ROMPALO*1, C.A. GAYDOS1, B. PARE1, K. CROTCHFELT1, G. MADICO1, R. DANIELS 1, K.V. SHAH 1, J.C. GAYDOS2, T.C. QUINN1,3, K. MCKEE4.1Johns Hopkins Univ., Baltimore, MD; 2Henry M. Jackson Foundation, Rockville, MD; 3 NIAID, NIH, Bethesda, MD; 4Ft. Bragg, NC

Etiology of Urethritis in Men Who Have Sex with Men. L. A. BORENSTEIN*, S. M. HARVEY, C. L. PEARCE, G. GATI, A. EFIRD, O. ZAIDEL, I. E. DYER, G. A. RICHWALD, P. J. KATSUFRAKIS. Los Angeles County Dept. of Health Services Publ. Health Lab. and STD Prog., and Los Angeles Gay and Lesbian Ctr., Los Angeles, CA

Fluoroquinolone-Resistant Neisseria gonorrhoeae in the United States. K.K. FOX , W.C. LEVINE, J.S. KNAPP. CDC, Atlanta, GA

Using Multiple Department of HealthDatabases To Optimize AIDS Surveillance: Opportunities and Pitfalls. S.W. FORLENZA*, F. VAZQUEZ , T.P. SINGH. New York City Dept. of Health , New York, NY


SS-11 $ 8.00 Slide Session 11: Reemerging Vaccine-Preventable Infections

Moderators:
RUDOLPH JACKSON, Department of Pediatrics, Morehouse College, Atlanta, GA
MYRON LEVINE, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD

Presentations:
Early Detection and Response to Serogroup A Meningococcal Disease Epidemics in Sub-Saharan Africa. J.A.D. LEAKE*, M. L. KONE, A.A. YADA, A. WARE, P. DEMBELE, N. ROSENSTEIN, K. ESTEVES, J. KAWAMATA, D.L. HEYMAN, B.A. PERKINS. CDC Atlanta, GA; WHO Subregional Office, Abidjan, Ivory Coast; Min. of Health (MOH), Burkina Faso; MOH Mali; Emerging and Other Communicable Diseases, WHO, Geneva.

Epidemiology of Diphtheria in Three Regions, Russia, 1994-96. C.R. VITEK1, K.M. BISGARD1 , M. BRENNAN1, V. SADOVNIKOVA2, P.M.I. STREBEL 1. 1 CDC, Atlanta, GA; 2 Ministry of Health, Russian Federation, Moscow, Russia

A Successful Adenovirus Vaccine Program That Failed. J. GAYDOS1,2*, R. NANG3, J. BRUNDAGE 1,3, C. GAYDOS 4, P. KELLEY 2, R. DE FRAITES5. 1Henry M. Jackson Foundation, Rockville, MD; 2 Walter Reed Army Inst. Res., Washington, DC; 3 USA Ctr. for Health Promotion and Preventive Med., Aberdeen PG, MD; 4 Johns Hopkins Univ., Baltimore, MD; 5 Office of the Army Surgeon General, Falls Church, VA


SS-12 $ 8.00 Slide Session 12: Influenza

Moderators:
EDWIN KILBOURNE, New York Medical College, Valhalla, NY
NANCY COX, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA

Presentations:
Global Monitoring of Influenza - FluNet. V. DIAS-FERRAO1, A. FLAHAULT2, K. ESTEVES1, P. CHABERTY2, A.J. VALLERON2, D. LAVANCHY1. 1 WHO, Geneva, Switzerland,2 Inst. National de la Sant‚ et de la Recherche M‚dicale (INSERM), Paris, France

Project Gargle, a World Wide Influenza Surveillance Program. L.C. CANAS*, J.S.ICE, L.L. TRENT. Epidemiologic Res. Div., Brooks AFB, San Antonio, TX

Antigenic Variants of Influenza Viruses Circulating in Asia as a Potential Source of Worldwide Epidemic Strains. A.KLIMOV*, H. REGNERY, H. HALL, C. BENDER, J. HUANG, K. SUBBARAO, N. COX. CDC, Atlanta, GA

Molecular Characterization of Human Influenza A(H5N1) Viruses. K. SUBBARAO*, C. BENDER, J. HUANG, S. CANTRELL, X. XU, M. SHAW, H. HALL, W. LIM, A. KLIMOV, N. COX. CDC, Atlanta, GA; Dept. of Health, Hong Kong, Special Administrative Region, China



SS-13 $ 8.00 Slide Session 13: Zoonoses

Moderators:
EMILIO DeBESS, Oregon Department of Human Resources, Portland, OR
CORRIE BROWN, College of Veterinary Medicine, University of Georgia, Athens, GA

Presentations:
Encephalitozoon hellem Infection in an Eclectus Parrot - Zoonotic Potential? N. PULPARAMPHIL, D. GRAHAM, D. PHALEN, K. SNOWDEN*. TX A&M Univ., Coll. of Vet. Med., Coll. Station, TX

Australian Fruit Bats (genus Pteropus) Are the Likely Reservoir Hosts of Three Newly Emerged Zoonoses. P. YOUNG, K. HALPIN, H. FIELD, J. MACKENZIE. Animal Res. Inst. and Univ. of Queensland, Brisbane, Queensland, Australia

Characterization of Ebola Virus Entry Using Pseudotyped Viruses. R. J. WOOL-LEWIS,* P. BATES. Dept. of Microbiology, Univ. of PA, State Coll., PA

Molecular Genetic Analysis of Phosphoprotein Gene of Equine Morbillivirus. A. TAMIN, B. R. NEWTON, A. SANCHEZ, T. KSIAZEK, W.J. BELLINI, P. A. ROTA. CDC, Atlanta, GA



SS-14 $ 8.00 Slide Session 14: Communicating to Prevent Emerging Infectious Diseases

Moderators:
ELAINE LARSON, School of Nursing, Georgetown University, Washington, DC
VICKI FREIMUTH, Office of Communication, CDC, Atlanta, GA

Presentations:
DPDx: Using the Internet to Strengthen Diagnosis of Parasitic Diseases. P. NGUYEN-DINH,* J.J. SULLIVAN, N. J. PIENIAZEK, M.J. ARROWOOD, A. W. HIGHTOWER, S.P. KACHUR, R. WIRTZ. CDC, Atlanta, GA

Use of an Innovative Health Communication to Control an Emerging Pathogen--VRE. R.L. SINKOWITZ-COCHRAN,* W.R. JARVIS. CDC, Atlanta, GA

Viral Hemorrhagic Fever Infection Control: Development and Evaluation of a Manual for Rural African Health Care Facilities. E.S. LLOYD, H.N. PERRY, M. THURIAUX. CDC, Atlanta, GA ; WHO, Geneva, Switzerland

Why Doctors Overprescribe Antibiotics: Results of Focus Group Discussions with Pediatricians and Family Physicians and Application to a Resistance Prevention Campaign. B. SCHWARTZ, L. BARDEN, S. DOWELL, C. LACKEY. CDC, Atlanta, GA



L-1 $ 8.00 Special Session L-1: Late-Breakers Session 1

Conveners:
D. PETER DROTMAN, NCID, CDC, Atlanta, GA
WALTER HIERHOLZER, NCID, CDC, Atlanta, GA; Yale University School of Medicine, New Haven, CT
STEPHEN OSTROFF, NCID, CDC, Atlanta, GA

Moderators:
STEPHEN OSTROFF, NCID, CDC, Atlanta, GA
SUZANNE BINDER, DPD, NCID, CDC

Presentations:
Multiple Resistance Patterns of Salmonella Isolates of Veterinary Origin. M.A. MILLER, P.J. FEDORKA-CRAY,V. TOELLE, K. HOLLINGER, L. TOLLEFSON. FDA-CVM, Rockville, MD; USDA-ARS-RRC, Athens, GA

P-3.2 Escherichia coli O157:H7 First Linked to Consumption of Alfalfa Sprouts. T. BREUER1, R. SHAPIRO1, W. HALL2, J. NEIMANN1, T.J. BARRETT1, S. DIETRICH2, F. DOWNES2, L. SLUTSKER1, P.M. GRIFFIN1.. CDC, Atlanta, GA1; MI Dept. of Com. Health, MI2

A Statewide Survey of Antibiotic Beliefs and Practices for Coughs and Colds in Colorado. K. GERSHMAN, M. LEFF, D. BRAND, S. LOWENSTEIN. CO Dept. of Health, Denver, CO

Human Infection with Ehrlichia ewingii, the Agent of Ozark Canine Granulocytic Ehrlichiosis. S.P. HMIEL, R. BULLER, M. ARENS, M. GAUDREAULT-KEENER, G.A. STORCH. WA Univ. Sch. of Med., St Louis, MO

Evidence for an Infectious Cause of Thrombotic Thrombocytopenic Purpura. S .R. TARANTOLO, J.D. LANDMARK, P.C. IWEN, T.L. MCDONALD, E.C. REED, M.R. BISHOP, W.C. CHAN, A. KESSINGER, S.H. HINRICHS. Univ. of NE Medical Ctr. and NE Publ. Health Lab., Omaha, NE



Wednesday, March 11

 

PS-09 $ 8.00 Plenary Session IX: Antimicrobial Resistance

Moderator:
THEODORE EICKHOFF, Division of Infectious Diseases, University of Colorado, Denver, CO

Speaker:
Antimicrobial Resistance. BARBARA MURRAY, University of Texas Medical School, Houston, TX



PS-11 $ 8.00 Plenary Session XI: Prions and Public Health

Moderator:
BRIAN MAHY, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA

Speaker:
The Emergence of Bovine Spongiform Encephalopathy and Related Diseases. SIR JOHN PATTISON, University College, London Medical School, London, UK



PS-12 $ 8.00 Plenary Session XII: Malaria

Moderator:
ADEL MAHMOUD, Case Western Reserve University, Cleveland, OH
Speaker: Malaria: An Emerging Disease in Africa. THOMAS NCHINDA, World Health Organization, Geneva, Switzerland



IP-13 $ 8.00 Invited Panel 13: Antimicrobial Resistance

Panel will address issues regarding the development, surveillance, prevention, and control of antimicrobial resistance in five major arenas: the hospital, the community, developing countries, veterinary medicine, and the clinical laboratory.

Conveners:
DAVID BELL, NCID, CDC, Atlanta, GA
BARBARA MURRAY, University of Texas Medical School, Houston, TX

Moderators:
DAVID BELL, NCID, CDC, Atlanta, GA
BARBARA MURRAY, University of Texas Medical School, Houston, TX

Speakers:
In the Hospital. WILLIAM JARVIS, Hospital Infectious Program, NCID, CDC, Atlanta, GA

In the Community. KEITH KLUGMAN, South African Institute for Medical Research, Johannesburg, South Africa

In Developing Countries. A. PIGNATARI, Sao Paulo, Brazil

In Veterinary Medicine. KLAUS STOEHR, World Health Organization, Geneva, Switzerland

In the Microbiology Laboratory. FRED TENOVER, Hospital Infections Program, NCID, CDC, Atlanta, GA



IP-14 $ 8.00 Invited Panel 14: Immigrant and Refugee Health

During the 1996 fiscal year, nearly 916,000 individuals were granted legal permanent resident status in the United States. Of this number, approximately 130,000 were refugees or asylum seekers. Nearly half a million of these immigrants and refugees arrive from developing countries where infectious diseases (e.g., tuberculosis, hepatitis, malaria, other parasites) are prevalent. Other developed nations, such as Australia and Canada, also receive migrants in proportion to their populations. This panel session will review the history and practice of immigration health screening interventions and the challenges posed by modern travel, population displacements and migration. Additionally, the identifiable and unknown personal and public health risks of migration will be examined and creative solutions to address these risks discussed. The impact of a specific disease, cholera, on the migration of people will be examined. Characteristics of public health emergencies involving large numbers of people and factors that make groups of people vulnerable to such emergencies will be defined. The impact of immigration on the health-care sector within a resettlement community will be described and the design of a cross-culturally effective health-care system will be outlined.

Conveners:
SUSAN COOKSON, Division of Quarantine, NCID, CDC, Atlanta, GA
BRIAN GUSHULAK, The International Organization for Migration, Geneva, Switzerland

Moderator:
RONALD WALDMAN, Office of Global Health, CDC, Atlanta, GA; Program on Health Consequences of Forced Migration, Columbia University School of Public Health, New York, NY
SUSAN COOKSON, Division of Quarantine, NCID, CDC, Atlanta, GA

Speakers:
Immigration Medicine: From Quarantine to Public Health Risk. BRIAN GUSHULAK, International Organization for Migration, Geneva, Switzerland

The Migrant Health Assessment: A Moving Target. DOUGLAS MacPHERSON, St Joseph's Hospital and McMaster University, Hamilton, Ontario, Canada

Cholera Among Refugee and Displaced Populations in Africa. CHRISTOPHE PAQUET, Epicentre, Paris, France

Public Health Emergencies in the Post-Cold War Era. FREDERICK BURKLE, University of Hawaii and Center of Excellence in Disaster Management and Humanitarian Assistance, Honolulu, HI

Medical Services Use by Immigrants and Refugees in Australia. ERICH KLIEWER, Manitoba Cancer Treatment and Research Foundation, Winnipeg, Manitoba, Canada

Refugee and Immigrant Health Care: The Minnesota Experience. PATRICIA WALKER, Health Partners Center for International Health, Regions Hospital, St. Paul, MN



IP-15 $ 8.00 Invited Panel 15: Global TB Issues and Challenges

This panel will discuss the current status of tuberculosis and drug-resistant tuberculosis as a global health problem. It will also describe advances towards the development of new tuberculosis vaccines and demonstrate a modeling approach to project the impact of improvements in the application of prevention and control measures. Finally, the panel will address the challenge posed by the need to protect health care workers from occupational tuberculosis in developing country settings.

Conveners:
KENNETH CASTRO, Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention (NCHSTP), CDC, Atlanta, GA
ANN GINSBERG, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD

Moderators:
ANN GINSBERG, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD
KENNETH CASTRO, Division of Tuberculosis Elimination, National Center for HIV, STD and TB Prevention, CDC, Atlanta, GA

Speakers:
The Epidemiology of Global Tuberculosis and Drug Resistance. MARIO RAVIGLIONE, Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland

Advances in Tuberculosis Vaccine Development. BARRY BLOOM, Howard Hughes Medical Institute, New York, NY

A Model to Project the Impact of Improved Tuberculosis Prevention and Control. CHRISTOPHER MURRAY, Harvard School of Public Health, Cambridge, MA

Risk of Mycobacterium tuberculosis Infection in Health-Care Workers, Brazil, and Thailand. DENISE GARRETT, Hospital Infections Program, NCID, CDC, Atlanta, GA



IP-16 $ 8.00 Invited Panel 16: Explaining the Unexplained in Clinical Infectious Diseases: Looking Forward

This symposium will address some aspects of current diagnostic approaches to frequently-difficult-to-diagnose infectious disease syndromes such as pneumonia. It will also take a look at what the future may hold as alternatives, or additions, to current diagnostic practices with some innovative possible solutions to the often vexing problem of explaining the unexplained in clinical infectious diseases.

Conveners:
C. J. PETERS, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA
BRADLEY PERKINS, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA
DAVID RELMAN, Palo Alto VA Medical Center, Palo Alto, CA

Moderators:
BRADLEY PERKINS, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA
DAVID RELMAN, Palo Alto VA Medical Center, Palo Alto, CA

Speakers:
Pneumonia: Evolving Diagnostic Practices. JOHN BARTLETT, Department of Medicine, Johns Hopkins University, Baltimore, MD

Pathologic Approach to the Diagnosis of Infectious Causes of Pulmonary Hemorrhage and Acute Repiratory Distress Syndrome. SHERIF ZAKI, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA

Novel Bioassay for Detection of Toxin-Mediated Illness. GARY KOVACS, Stanford University, Stanford, CA

Cellular Scouts: Genome-wide Expression Monitoring of Peripheral Blood Lymphocytes To Detect and Characterize Pathogens. MICHAEL EISEN, Stanford Univ. Sch.of Med., Stanford, CA



IP-17 $ 8.00 Invited Panel 17: Blood Safety

The blood supply is currently safer than it has ever been. However, since blood is a human tissue, it is a natural vehicle for transmission of infectious diseases. The Blood Safety Panel will include invited presentations on the risk of transmission of selected emerging pathogens through transfusion of blood and blood products and the development and evaluation of effective prevention strategies, including diagnostic screening tests, donor deferral strategies, and viral inactivation procedures. The panel will conclude with a roundtable discussion on decision making related to the processes, policies, and resources needed to maintain an adequate supply of safe blood and blood products.

Conveners:
MARY CHAMBERLAND, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA
ROGER DODD, American Red Cross, Washington, DC
JAY EPSTEIN, Food and Drug Administration (FDA), Washington, DC
RIMA KHABBAZ, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA

Moderators:
MARY CHAMBERLAND, Division of Viral and Rickettsial Diseases, NCID, CDC, Atlanta, GA
JAY EPSTEIN, Food and Drug Administration, Washington, DC

Speakers:
ROGER Y. DODD, American Red Cross, Washington, DC
ROBERT G. WILL, National Creutzfeldt-Jakob Disease Surveillance Unit, Western General Hospital, Edinburgh, Scotland
DAVID PERSING, The Mayo Clinic, Rochester, MN
JEAN EMMANUEL, World Health Organization, Geneva, Switzerland
ALFRED DEMARIA, Jr., Massachusetts Department of Public Health, Boston, MA
GLENN PIERCE, Blood Safety Working Group, National Hemophilia Foundation, New York, NY

LS-03 $ 8.00 LUNCHEON SESSION 03: Emerging Infectious Diseases: The Author's Perspective

Convener:
ROBERT HOWARD, NCID, CDC, Atlanta, GA

Moderators:
ELI ABRUTYN, Health Sciences, Allegheny University, PA
ROBERT HOWARD, NCID, CDC, Atlanta, GA

Speakers:
ROBIN COOK (Toxin)
PATRICIA CORNWELL (Unnatural Exposure)
NICHOLS FOX (Spoiled)
LAURIE GARRETT (The Coming Plague)



SP-04 $ 8.00 Special Session 04: Innovative Information Sharing Strategies

National and global health issues accentuate the need for health professionals to rapidly and effectively acquire and disseminate information. This session will highlight three innovative systems for communicating health information. Presenters will address each system in the context of their function and the issues that drove its establishment.

Convener:
BRADFORD KAY, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA

Moderators:
BRADFORD KAY, Division of Bacterial and Mycotic Diseases, NCID, CDC, Atlanta, GA
RALPH TIMPERI, Massachusetts State Laboratory Institute, Jamaica Plain, MA

Speakers:
ProMed. STEPHEN S. MORSE, Defense Advanced Research Projects Agency, Arlington, VA

WHONET. THOMAS O'BRIEN, Department of Microbiology, Brigham and Women's Hospital, Boston, MA

VTMEDNET. JULIE McGOWAN, Charles A. Dana Medical Library, University of Vermont, Burlington, VT

TeleMed. DAVID FORSLUND, Advanced Computing Laboratory, Los Alamos National Laboratory, Los Alamos, NM



SS-15 $ 8.00 Slide Session 15: Antimicrobial Resistance

Moderators:
WILLIAM MARTONE, National Foundation for Infectious Diseases, Washington, DC
GERALD STOKES, Department of Microbiology and Immunology, School of Medicine, George Washington University, Washington, DC

Presentations:
Knowledge, Attitudes and Practices of Caregivers Regarding Antibiotic Use for Children`s Upper Respiratory Infections. M.J. TREPKA, 1,2 * E.A. BELONGIA3, J.P. DAVIS2. 1CDC, Atlanta, GA; 2WI Div. of Health, Madison, WI; 3Marshfield Medical Res. Fndn., Marshfield, WI

An Outbreak of Multidrug-Resistant Salmonella Serotype Typhimurium Definitive Type 104 (DT 104) Infections in Humans and Cattle in Vermont. C.R. FRIEDMAN, R.C. BRADY, M.J. CELOTTI, S.E. SCHOENFELD, R.H. JOHNSON, P.D. GALBRAITH, J.K. CARNEY, K. ROBBINS, L. SLUTSKER. CDC, Atlanta, GA; USDA, Sutton, MA; VT Dept. of Health, Burlington, VT

Antimicrobial Resistance and Mortality in Four Intensive Care Units in Mexico. M. ZAIDI,* J. SIFUENTES, A.L. ROLON, R. ROSADO, G. VAZQUEZ, J.J.CALVA, S. PONCE DE LEON. Hosp. Gen. O Horan, Merida, Yuc.,Inst. Nal. Nutricion, Mexico City, Hosp. Gen. Morelia, Morelia, Mich. Mexico

BHI Vancomycin Agar Screening Test for Detection of Staphylococcal Isolates Exhibiting Decreased Susceptibility to Vancomycin. B.C. HILL, * M.V. LANCASTER, F. C. TENOVER. CDC, Atlanta, GA

Methicillin Resistant Staphylococcus aureus (MRSA) in a Child Care Centre. R. SHAHIN, I. JOHNSON*, L. FORD-JONES, F. JAMIESON, A. MCGEER, B. YAFFE, B. MEDERSKI. City of North York Publ. Health Dept., Hosp. for Sick Children, Ontario Min. of Health, Mt. Sinai Hosp., North York General Hosp., Toronto, Ontario, Canada

Fluoroquinolone-Resistant Campylobacter Isolated from Humans and Poultry in Minnesota. K.E. SMITH*1,2, J.M. BESSER2, F. LEANO2, J.B. BENDER2, J.H. WICKLUND, B. JOHNSON2, C.W. HEDBERG2, K. VOUGHT3, K.L. MACDONALD2, M.T. OSTERHOLM2. 1CDC, Atlanta, GA; 2MN Dept. of Health, Minneapolis, MN, 3MN Dept. of Agri., St. Paul, MN



SS-16 $ 8.00 Slide Session 16: Hepatitis E and Other Waterborne Agents

Moderators:
DENNIS JURANEK, Division of Parasitic Diseases, NCID, CDC, Atlanta, GA
CLADD STEVENS, Laboratory of Epidemiology, The New York Blood Center, New York, NY

Presentations:
An Observational Cohort Study of Hepatitis E in Pregnancy. R.M.C.N. SCOTT, M.P. SHRESTHA, D.W. VAUGHN, K. NORKYL, M. HADA, J. THAPA, K.S.A. MYINT, M.R. BOMGAARS, B.L. INNIS*. Armed Forces Res. Inst. of the Medical Sciences, Bangkok, Thailand; Patan Hosp., Lalitpur, Nepal; Walter Reed Army Inst. of Res., Washington, DC

Hepatitis E Virus (HEV) Excretion in Feces of Patients from Disease-Endemic Areas and Experimentally Infected Primates. R. AGGARWAL,* K.A. MCCAUSTLAND, M.A. PURDY, J. SPELBRING, K. KRAWCZYNSKI. CDC, Atlanta, GA; Sanjay Gandhi Postgraduate Inst. of Medical Sciences, Lucknow, India

Detection of Cryptosporidium parvum Using Flow Cytometry. D. COLE,* R. SMITH, K. SNOWDEN, N. COHEN. Coll. of Vet. Med., TX A&M Univ., College Station, TX

Vibrio Cholerae Surveillance in Peru. C. CARRILLO, I. ARIAS, M. ZAMUDIO, M. FIGUEROA. Instituto Nacional de Salud, Peru

A Large Outbreak of Cryptosporidiosis Associated with a Water Sprinkler Fountain. V. DENEEN, K. SMITH, P. BELLE-ISLE, C. TAYLOR, L. GABRIEL, J. BENDER, C. HEDBERG, TEAM DIARRHEA. MN Dept. of Health., Minneapolis, MN

Emerging Pathogens: Regulatory Considerations for Drinking Water. S.A. SCHAUB,* P.S. BERGER. U.S. EPA, Washington, DC



SS-17 $ 8.00 Slide Session 17: TB in Institutions and Around the Globe

Moderators: NANCY BINKIN, Division of TB, National Center for HIV, STD, and TB Prevention, CDC, Atlanta, GA
KERRI-ANN JONES, Office of Science and Technology Policy, Washington, DC

Presentations:
Surveillance of Antituberculous Drug Resistance in Peru 1995-96. *L. VASQUEZ, L. ASENCIOS, N. QUISPE , S. DIAZ, C. CARILLO, J. PORTOCARRERO, P. SUAREZ, R. CANALES, E. ALARCON, A. YI CHU, J. AGAPITO , I. SABOGAL, A. TORRES. Instituto Nacional de Salud, Ministerio de Salud, Peru

Status of Tuberculosis Infection Control Programs at U.S. Hospitals, 1989-1996. L. P. MANANGAN,* D. N. SIMONDS, G. PUGLIESE, J. R. RUDNICK, S. N. BANERJEE, K. KROC, K. STEINGRABER, W. R. JARVIS. CDC, Atlanta, GA; Am. Hosp. Assoc., Chicago, IL

Moldova and the Global Tuberculosis Emergency. N . BANATVALA,* D. TRACEY, J. PAUL, F. DROBNIEWSKI, A. LEORDA, D.R VANGHELI, G. TAMBALARI. MERLIN, UK; Natl. TB Reference Ctr. ,UK; Prison Health Svc. and Pulmophthsiatry Inst., Moldova

Re-Emergence of Tuberculosis: Epidemiology of TB at an Urban Medical Center in the 1990s. M.J. SOTIR, P. PARROTT , B. METCHOCK, J.E. McGOWAN, S.M. RAY, N.N. BOCK, H.M. BLUMBERG . Emory Univ. Sch. of Med., Atlanta, GA; Grady Memorial Hosp., Atlanta, GA; GA Div. of Publ. Health, Atlanta, GA

Missed Opportunities for Preventive Therapy for Tuberculosis Among Foreign-born Persons Applying for Adjustment of Immigration Status, San Diego, 1996. M. SARAIYA1, R. CASS 2 , P. TRIBBLE3,* K. MOSER2, N. BINKIN1. 1CDC, Atlanta, GA; 2 San Diego County Dept. of Health, San Diego, CA; 2CDC, Atlanta, GA

Tuberculosis Isolation Practices for Pneumonia Patients Admitted through the Emergency Department. G.J. MORAN ,* D.A. TALAN, S. ONG, W. MOWER, G. MERCHANT, M. KUEHNERT, W.R. JARVIS , EMERGEncy ID NET Study Group. Olive View-UCLA Dept. of Emergency Med.; UCLA Sch.of Med., Los Angeles, CA; CDC, Atlanta, GA



SS-18 $ 8.00 Slide Session 18: Emerging Infections and the Health Care System

Moderators:
DONALD ARMSTRONG, Memorial Sloan-Kettering Cancer Center, New York, NY
JULIE GERBERDING, Epidemiology and Prevention Interventions Center, San Francisco General Hospital, San Francisco, CA

Speakers:
Emerging Nosocomial Infections in Medical Intensive Care Units in the United States. M. RICHARDS,* J. EDWARDS, D. CULVER, R. GAYNES, NNIS SYSTEM. CDC, Atlanta, GA

Risk Factors for Bloodstream Infection (BSI) in Patients Receiving Home Infusion Therapy (HIT). J. TOKARS*, S. COOKSON, M. MCARTHUR, C. BOYER, A. McGEER, W. JARVIS. CDC, Atlanta, GA; Mt Sinai/Princess Margaret Hospitals, Toronto, ON, Canada; Cleveland Clinic Foundation, Cleveland, OH

Epidemic Nosocomial Microbacterium Bacteremia In Cancer Patients. J. ALONSO-ECHANOVE, S.S. SHAH, W.R. JARVIS. CDC, Atlanta, GA

Tick-borne Illness in National Guard Blood Donors Training at Fort Chaffee, Arkansas. T. TREADWELL* 1, P. ARGUIN1, L. ROTZ 1, L. TENGELSEN1, M. CHAMBERLAND1, P. QUINLISK 2, T. SAFRANEK3, T. McCHESNEY4, M. CRUTCHER5, B. BRACKIN6, J. OLSON1 .... . 1CDC, Atlanta, GA; 2IA Dept. Publ. Health, Des Moines, IA; 3 NE Health and Human Svcs., Lincoln, NE; 4AR Dept. of Health, Little Rock, AR; 5OK State Health Dept., Oklahoma City, OK; 6MS State Health Dept., Jackson, MS



SS-19 $ 8.00 Slide Session 19: Global Migration: Health Assessment of Refugees and Other Mobile Populations

Moderators:
ROBERT WAINWRIGHT, Division of Quarantine, NCID, CDC, Atlanta, GA
CIRO DE QUADROS, Pan American Health Organization, World Health Organization, Washington, DC

Presentations:
Early Identification of Health Conditions Among Florida's Refugee Population. J. R. RIDGE.*. FL Dept. of Health, Tallahassee, FL

Rwanda Massive Repatriation Movement in November 1996. Assessment of the Public Health Consequences. M. NEIRA1 R. WALDMAN2. 1World Health Organization, Geneva, Switzerland, 2 B.A.S.I.C.S, Arlington, VA

Expanding the Role of Refugee Medical Screening: Moving Beyond Screening for Inadmissible Conditions. J. M. MILLER*, S. COOKSON, H. BOYD, S. OSTROWSKI, S. GONZAGA, V. KEANE, L. O BRIEN, P. NGUYEN-DINH, S. WAHLQUIST, U. PATEL, J. CHALA, R. MOYER, M. CETRON, R. WAINWRIGHT. CDC, Atlanta, GA; USAF, CA; International Organization for Migration, Geneva, Switzerland; Mombasa Hospital, Mombasa, Kenya

Infectious Disease Morbidity in the U.S. Region Bordering Mexico. T. J. DOYLE, P. ELLINAS, R. T. BRYAN. CDC, Albuquerque, NM; Univ. of AZ, Phoenix, AZ.



SS-20 $ 8.00 Slide Session 20: Characterizing the Unknown: Molecular Tools and Syndrome Surveillance and Diagnosis

Moderators:
DAVID FRASER, INCLEN, Philadelphia, PA
JAMES STEINBERG, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA

Presentations:
Differential Diagnosis of Hantavirus Pulmonary Syndrome. T. J. DOYLE, D. COULTAS, J. YOUNG, A. S. KHAN, C. J. PETERS, R. T. BRYAN. CDC, Atlanta, GA; Univ. of NM, Albuquerque, NM

A Computational Model of Viral Evolution and Emergence. D. BURKE,* A. WU, C. RAMSEY, K. DEJONG, J. GREFENSTETTE. Johns Hopkins Univ. Sch. of Hyg. and Publ. Health, Baltimore, MD; Navy Ctr. for Applied Res. in Artificial Intelligence, Washington, DC

Surveillance for Unexplained Deaths and Critical Illnesses Due to Possible Infectious Causes. R. HAJJEH*, J. FLOOD, P . CIESLAK, D. RELMAN, F. LOPEZ, M. HENDRY, C. WOODS, L. CONN, S . NASH, S . ZAKI, A . REINGOLD, J. HADLER, R. DANILA, J. RAINBOW, C. HEYE, S. LADD-WILSON, B. PERKINS , UNEXPLAINED ILLNESS WORKING GROUP. CDC, Atlanta, GA; CA Emerging Infect. Program and Stanford Univ., San Francisco, CA; CT Emerging Infect. Program, Hartford, CT; MN Dept of Health, Minneapolis, MN; OR Health Division, Portland, OR

The Role of Pathology in Studies of Emerging Infectious Diseases Associated with Acute Respiratory Distress Syndrome. W-J. SHIEH,* P. GREER, T. FEREBEE, C. GOLDSMITH, J. GUARNER, S.R. ZAKI. CDC, Atlanta, GA



SS-21 $ 8.00 Slide Session 21: Malaria

Moderators:
GEORGE HILL, International Health Programs, Meharry Medical College, Nashville, TN
DANIEL COLLEY, Division of Parasitic Diseases, NCID, CDC, Atlanta, GA

Presentations:
Active Laboratory-based Surrveillance for Malaria. A.F. CHU*, M. LAYTON, MILLER. New York City Dept. of Health, New York, NY

Emerging In-vivo Resistance to Co-trimoxazole Among Plasmodium falciparum Isolates in Western Uganda. T. JELINEK* 1,2, A.H.D. KILIAN1,3, M. T. DURAISINGH2, G. KABAGAMBE3, F. VON SONNENBURG2, T. Lâ„¢SCHER2, D. C. WARHURST1. 1 London Sch. of Hygiene and Trop. Med. Dept. of Medical Parasitology, London, UK; 2 Depart. of Infect. Dis. and Trop. Med., Univ. of Munich, Munich, Germany; 3 Basic Health Svcs., GTZ, Fort Portal, Uganda

Current Strategies in Antimalarial Drug Development. W.K. MILHOUS, K.U. LEO, C.K. OHRT, R.P. BRUECKNER, D.E. KYLE, H. LOBEL. Experimental Therapeutics, Walter Reed Army Inst of Res., Washington, DC; CDC, Atlanta, GA

Re-emergence of Plasmodium vivax Malaria in the Republic of Korea. S. CRAIG , W. HEWITSON, B. FEIGHNER, W. NOVAKOSKI, D. STRICKMAN , L. KEEP, C. BELL, E. EVANS, C. OCKENHOUSE.. U.S. Army Ctr. for Health Promotion and Preventive Med., APG, MD; 18th Medical Command, Republic of Korea; Walter Reed Army Inst. of Res., Washington, DC



CGS $ 16.00 (2 Tapes) Closing General Session

Convenor:
D. PETER DROTMAN, NCID, CDC, Atlanta, Ga

Moderators:
JAMES HUGHES. NCID. CDC. Atlanta. GA
STANLEY FALKOW, School of Medicine, Stanford University, Stanford, CA, President, American Society for Microbiology

Speakers:
SIR GEORGE ALLEYNE, Pan American Health Organization, Washington, D.C.
STANLEY FALKOW, School of Medicine, Stanford University, Stanford, CA, President, American Society for Microbiology
LAURIE GARRETT, Pulitzer Prize-winning author & journalist, New York, NY
Closing Remarks & Adjourn, JAMES HUGHES, NCID, CDC, Atlanta, GA


 

TOP OF PAGE

 


 

Audio Cassette Prices

$ 8.00 / Tape
or
Convention Special
ANY 12 TAPES & FREE Binder for
$80.00, or ENTIRE SET for $400.00

DESCRIPTION QTY EACH SUBTOTALS
Special: ANY 12 TAPES + FREE binder ($80), or FULL SET ($400) x $80.00 =
Individual Tapes x $ 8.00 =
Extra Binder for 6 Cassettes x $4.00 =
Extra Binder for 12 Cassettes x $6.00 =
Subtotal of above:
Sales Tax (Texas Residents add 8.25%):
Shipping and Handling $4.00 US; $9.00 Foreign:
US Purchase Orders NOT paid in full, add $5.00:
TOTAL REMITTED:

Name        
Address        
City State    
Country Zip    
E-mail Phone    
Payment Method Card# Exp. Date